These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9301261)

  • 1. [Single photon emission computed tomography in the diagnosis of Alzheimer's disease].
    Hanyu H; Asano T; Abe S; Arai H; Takasaki M; Shindo H; Abe K
    Nihon Ronen Igakkai Zasshi; 1997 Jun; 34(6):468-73. PubMed ID: 9301261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.
    Song IU; Chung YA; Chung SW; Jeong J
    Dement Geriatr Cogn Disord; 2014; 37(5-6):276-85. PubMed ID: 24356537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease].
    Arbizu J; Larumbe R; Gámez C; Martí J; Martínez-Lage J; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):252-60. PubMed ID: 10481106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.
    Lobotesis K; Fenwick JD; Phipps A; Ryman A; Swann A; Ballard C; McKeith IG; O'Brien JT
    Neurology; 2001 Mar; 56(5):643-9. PubMed ID: 11245717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
    Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
    Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
    Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of Alzheimer's disease using brain SPECT with three-dimensional stereotactic surface projections].
    Hanyu H; Asano T; Kogure D; Abe S; Iwamoto T; Takasaki M
    Rinsho Shinkeigaku; 2001 Sep; 41(9):582-7. PubMed ID: 11968741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
    Ishii K; Mori E; Kitagaki H; Sakamoto S; Yamaji S; Imamura T; Ikejiri Y; Kono M
    Clin Nucl Med; 1996 Feb; 21(2):106-10. PubMed ID: 8697677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment.
    Osimani A; Ichise M; Chung DG; Pogue JM; Freedman M
    Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Imabayashi E; Soma T; Sone D; Tsukamoto T; Kimura Y; Sato N; Murata M; Matsuda H
    Ann Nucl Med; 2017 Aug; 31(7):536-543. PubMed ID: 28547521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease.
    Lee YC; Liu RS; Liao YC; Sun CM; Wang PS; Wang PN; Liu HC
    Eur Neurol; 2003; 49(3):142-5. PubMed ID: 12646756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hanyu H; Hirao K; Sato T; Iwamoto T; Koizumi K
    Ann Nucl Med; 2008 Dec; 22(10):911-6. PubMed ID: 19142710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.